Recall
FDAHealthJune 12, 2026

Par Health USA, LLC — Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For Intramuscular or Intravenous use, Manufactured for: Endo USA, Malvern, PA 19355

⚠️ Crystallization; identified as Buprenorphine free base

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
June 12, 2026

Nationwide in the USA.

What's affected?

Product
Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For Intramuscular or Intravenous use, Manufactured for: Endo USA, Malvern, PA 19355, NDC 42023-179-05
Lot code
82886

Additional details

Lot #: 82886, exp 09/30/2026; 89646, exp 05/31/2027

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 46,334 units.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.